Nimesulide banned: ‘More than 100 mg…’, Govt bans ‘this’ painkiller drug as dangerous for health
Nimesulide banned News Marathi: Central Govt Painkiller An important decision has been taken regarding the drug and a major step has been taken regarding the pain reliever Nimesulide. Due to health safety concerns, the manufacture, sale and distribution of oral nimesulide tablets containing more than 100 mg has been banned with immediate effect. The decision was taken under Section 26A of the Drugs and Cosmetics Act, 1940. The government has said that the drug can be dangerous to health. There are many safe options available in the market.
Pilgrims throng on New Year’s Eve; 2 km long darshan line
Why was it banned?
The Ministry of Health issued a notification, stating that nimesulide tablets containing more than 100 mg may pose a risk to humans. It is a non-steroidal anti-inflammatory drug (NSAID) and can have adverse effects on the liver. The drug’s toxicity and other side effects are being investigated worldwide. The government decided to ban the drug after consulting the Drugs Technical Advisory Board. Nimesulide has now been banned across the country with immediate effect.
Dangers of pain relievers
The Ministry of Health has taken this step keeping in mind the dangers of painkillers to humans, so that there is no threat to public health. An overdose of painkillers can cause adverse effects on the liver and kidneys. Doctors recommend using painkillers in moderation. Also, you should always take painkillers only after consulting a doctor.
Veterinary drugs are already banned
In January this year, the government had already banned all nemocid drugs for use in animals. This was due to environmental concerns, as the drug posed a threat to vultures when used on cows. The study found that the vultures died within 24 hours of taking the drug.
Drug hazards
Nimoside was introduced in Italy in 1985 and belongs to the NSAID (non-steroidal anti-inflammatory drug) category. It is not approved in many countries around the world, including the United States, United Kingdom, Canada, Australia, New Zealand, and Japan. Long-term use can cause liver toxicity, bleeding, kidney damage, and skin rashes.
Current situation in India
In 2011, India banned the use of Nimocide in children, but allowed its use in elderly patients. In March 2023, the Pharmacopoeia Commission of India warned that the drug may also cause definite drug eruption (repeated rash in the same area).
Comments are closed.